Marsillach_2009_Clin.Biochem_42_91

Reference

Title : The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment - Marsillach_2009_Clin.Biochem_42_91
Author(s) : Marsillach J , Aragones G , Beltran R , Caballeria J , Pedro-Botet J , Morcillo-Suarez C , Navarro A , Joven J , Camps J
Ref : Clinical Biochemistry , 42 :91 , 2009
Abstract :

AIMS: We investigated the analytical performance of a new assay of the lactonase activity of paraoxonase-1 and its efficacy in the assessment of liver damage. DESIGN AND
METHODS: Serum lactonase activity was determined by the hydrolysis of 5-thiobutyl butyrolactone in 633 healthy individuals and 369 patients with chronic liver disease. Paraoxonase-1, 2, and 3 gene polymorphisms were analyzed by the MassArray method.
RESULTS: Linearity was up to 10 U/L. Detection limit was 0.12 U/L. Imprecision was < or = 17.7%. Lactonase values in our normal population were 5.99 (3.29-13.61) U/L. Lactonase activity showed a lower influence of genetic polymorphisms than the classical assay using paraoxon. Both measurements showed a similar efficiency in testing for liver dysfunction. CONCLUSION: We report a reliable assay using a non-toxic substrate for the measurement of serum lactonase activity. The influence of genetic variability is low. The assay could be a useful addition to tests evaluating liver impairment.

PubMedSearch : Marsillach_2009_Clin.Biochem_42_91
PubMedID: 18977341

Related information

Citations formats

Marsillach J, Aragones G, Beltran R, Caballeria J, Pedro-Botet J, Morcillo-Suarez C, Navarro A, Joven J, Camps J (2009)
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment
Clinical Biochemistry 42 :91

Marsillach J, Aragones G, Beltran R, Caballeria J, Pedro-Botet J, Morcillo-Suarez C, Navarro A, Joven J, Camps J (2009)
Clinical Biochemistry 42 :91